Arcus Biosciences, Inc. Intellectual Property Contracts & Agreements
7 Contracts & Agreements
- License Agreements (7 contracts)
- Third Amendment dated May 10, 2021 to the License Agreement dated August 16, 2017 between Arcus Biosciences, Inc. and WuXi Biologics Ireland Limited (Filed With SEC on August 5, 2021)
- Amendment No. 2 dated March 2, 2020 to the License Agreement dated August 16, 2017 between Arcus Biosciences, Inc. and WuXi Biologics (Cayman) Inc (Filed With SEC on March 5, 2020)
- Amendment No. 1 dated June 27, 2019 to the License Agreement dated August 16, 2017 between Arcus Biosciences, Inc. and WuXi Biologics (Cayman) Inc (Filed With SEC on August 6, 2019)
- Amendment No. 1 to Option and License Agreement, dated September 19, 2017, between Arcus Biosciences, Inc. and Taiho Pharmaceutical Co, Ltd (Filed With SEC on November 8, 2018)
- Option and License Agreement, dated September 19, 2017, between the Registrant and Taiho Pharmaceutical Co., Ltd (Filed With SEC on February 16, 2018)
- License Agreement, dated August 16, 2017, between the Registrant and WuXi Biologics (Cayman) Inc (Filed With SEC on February 16, 2018)
- License Agreement, dated December 8, 2016, between the Registrant and Abmuno Therapeutics LLC (Filed With SEC on February 16, 2018)
